Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 291
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05705700 | Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP) | ||
| NCT02074631 | Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation | ||
| NCT02046291 | Safety of Romiplostim (Nplate®) Following UCBT | ||
| NCT00295880 | Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer | ||
| NCT00176878 | Stem Cell Transplant for Bone Marrow Failure Syndromes | ||
| NCT00287859 | Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | ||
| NCT06792825 | HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL | ||
| NCT01312818 | Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) | ||
| NCT03125642 | Auto Stem Cell Transplant for Lymphoma Patients | ||
| NCT00281827 | Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer | ||
| NCT05708703 | Assessing the Time Demands of Cancer | ||
| NCT02666105 | Exemestane in Post-Menopausal Women With NSCLC | ||
| NCT07070726 | UNTOLD Ovarian Cancer Unmet Needs Survey | ||
| NCT00177047 | Autologous Transplant for Multiple Myeloma | ||
| NCT03152526 | CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR | ||
| NCT00003926 | Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | ||
| NCT01385423 | Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML) | ||
| NCT02145039 | Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases | ||
| NCT04555811 | FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL | ||
| NCT04003805 | Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users | ||
| NCT05805605 | Allo HSCT Using RIC and PTCy for Hematological Diseases | ||
| NCT00612716 | Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia | ||
| NCT00167206 | Stem Cell Transplantation for Fanconi Anemia | ||
| NCT00000105 | Vaccination With Tetanus and KLH to Assess Immune Responses. | ||
| NCT03850704 | Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma | ||
| NCT00319748 | Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers | ||
| NCT04928950 | Charcoal in Lung Cancer Patients Undergoing TEMLA | ||
| NCT02141451 | ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL | ||
| NCT00265863 | Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites | ||
| NCT00287885 | Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | ||
| NCT01566682 | A Multi-Center Trial of the ProLung Test™ | ||
| NCT00379197 | Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer | ||
| NCT02162420 | Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia | ||
| NCT01464359 | T-Cell Depleted Double UCB for Refractory AML | ||
| NCT01593618 | Empowering Cancer Survivors Through Information Technology | ||
| NCT00871689 | Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML | ||
| NCT00680667 | Clinical Trial of Trametes Versicolor in Women With Breast Cancer | ||
| NCT00005987 | Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | ||
| NCT02227797 | MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients | ||
| NCT05025774 | Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise | ||
| NCT00638820 | Reduced Intensity AlloTransplant For Osteopetrosis | ||
| NCT00602446 | Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant | ||
| NCT03019666 | Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL | ||
| NCT03417154 | Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS | ||
| NCT06412497 | MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure. | ||
| NCT00703638 | Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors | ||
| NCT00630253 | Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia | ||
| NCT00775931 | Allogeneic Transplantation For Severe Osteopetrosis | ||
| NCT00432094 | Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors | ||
| NCT06322992 | App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3 |
